Press "Enter" to skip to content

Tag: covid-19

The slow, halting and confused response to the Coronavirus outbreak in USA

by Matt Hancock, organization development consultant

In the same day that the United States Senate approved the largest economic stimulus package in history, Americans learned that there were now more cases of COVID-19 in the US than in any other country, surpassing both China and Italy.

Map of essential undertakings (DPCM 11 and 22 March 2020) by province

by Davide Dazzi, OpenCorporation

After the publication of the DPCM (Prime Ministerial Decree) of 22 March and the list of ateco codes[1] of companies deemed essential, a surreal debate ensued, one to which we wish to participate offering some maps and data on the number of potentially open or closed companies and related employees following the implementation of the decrees

Mappa delle imprese essenziali (DPCM 11 e 22 marzo 2020) per provincia

a cura di Davide Dazzi, Ires Emilia-Romagna e OpenCorporation

Dopo la pubblicazione del DPCM del 22 marzo con l’elenco dei codici ateco delle attività ritenute essenziali, si è aperto un dibattito surreale a cui anche noi, tuttavia, vogliamo partecipare offrendo alcune mappe e dati sul numero di imprese potenzialmente aperte e chiuse e i relativi dipendenti in applicazione dei decreti

COVID-19 and the various national healthcare systems: elements for comparison

di Davide Dazzi, Ires Emilia-Romagna e OpenCorporation

The Covid-19 virus has inevitably rekindled attention towards the balance of the health system and the different models of relationship between public and private not only in Italy but also on a global level. In fact, it’s clear how much of the American democratic primaries has been played on the different scenarios, proposed by the various candidates, regarding interventions on public healthcare. The national response to Covid-19 is closely dependent on the responsiveness of the health system and how public and private will work together. It is therefore important to understand the structural characteristics of national health systems in order to understand also how the difficulties in present response depends on previous “political”

Il COVID-19 e i diversi sistemi sanitari nazionali: alcuni elementi di comparazione

di Davide Dazzi, Ires Emilia-Romagna e OpenCorporation

La risposta nazionale al Covid-19 è strettamente dipendente dalla capacità di reazione del sistema sanitario e da come pubblico e privato sapranno collaborare. Diventa quindi importante capire le caratteristiche strutturali dei sistemi sanitari nazionali per comprendere anche come la difficoltà di risposta nel presente dipenda da scelte “politiche” pregresse

#CoronaVirus COVID-19 Observatory #OpenCorporation, from start-ups to Big-Pharma, all the companies committed in #vaccine research

di Gabriele Guglielmi, FIlcams Cgil

From USA to Europe, from China to Israel: Moderna, Inovio, Gsk, Gilead, Regeneron, Sanofi, Takeda, Vir, Johnson & Johnson, Sanofi, Irbm, Roche,HEAT BIOLOGICS , Diasorin. 3M